Cerebrovascular disease has an important role in cognitive decline and dementia. In this context, cerebral microinfarcts are attracting increasing attention, but these lesions could thus far not be detected in vivo. The aim of this study was to try to identify possible cortical microinfarcts on high-resolution 7T in vivo magnetic resonance imaging (MRI) and to perform a histopathologic validation study on similar appearing lesions on 7T ex vivo MRI of postmortem brain tissue. The study population consisted of 22 elderly subjects, who underwent 7T MRI. The fluid attenuated inversion recovery, T 2 , and T 1 weighted scans of these subjects were examined for possible cortical microinfarcts. In the ex vivo MRI study, 15 formalin-fixed coronal brain slices of 6 subjects with Alzheimer and vascular pathology were examined and subjected to histopathologic verification. On the in vivo scans, 15 cortical lesions could be identified that were likely to be microinfarcts in 6 subjects. In the postmortem tissue, 6 similar appearing lesions were identified of which 5 were verified as cortical microinfarcts on histopathology. This study provides strong evidence that cortical microinfarcts can be detected in vivo, which will be of great value in further studies into the role of vascular disease in cognitive decline and dementia.
INTRODUCTION
Cognitive decline and dementia are major manifestations of cerebrovascular disease. Approximately one in five patients with acute stroke develops dementia within a year after stroke. 1 Even more often, cerebrovascular disease is involved in cognitive decline or dementia in people without an obvious history of stroke. Autopsy studies identify vascular pathology in the majority of patients with dementia, also in those with a clinical diagnosis of Alzheimer's disease (AD). 2, 3 This vascular pathology frequently involves the small vessels of the brain, including small arteries and arterioles, but also capillaries and small veins, and is referred to as cerebral small vessel disease (SVD). 4 Imaging correlates of SVD on conventional brain magnetic resonance imaging (MRI) include lacunar infarctions, white matter hyperintensities (WMHs), and microbleeds. 4 Importantly, these MRI lesions do not fully capture the burden of vascular damage in aging and dementia. In this context, cerebral microinfarcts (CMIs) are attracting increasing attention. They are considered to be the single most widespread form of brain infarction and thus a major component of the causal pathway between SVD and cognitive dysfunction. 5, 6 On autopsy, CMIs are observed in around 43% in patients with AD, 62% in patients with vascular dementia, and 24% in nondemented elderly subjects. 6 Cerebral microinfarcts are typically defined as sharply delineated microscopic ischemic lesions accompanied by cellular death or tissue necrosis, often associated with gliosis and cavitation. 2, 7 Cerebral microinfarcts can occur in both the whitematter and (sub)cortical regions of the brain, presumably more so in watershed areas. 6, 8 Because of their small sizes (ranging from 50 mm to a few mm), CMIs escape detection by regular clinical MRI protocols. With the introduction of high field strength (7.0 T) MRI, which allows high-resolution imaging with isotropic voxel sizes in the submillimeter range, CMIs may be visualized in vivo. The aim of this study was to try to identify possible CMIs on 7.0 T magnetic resonance (MR) images of elderly subjects without a known history of dementia, and to perform a histopathologic validation study on similar appearing lesions on 7.0 T MR images of postmortem brain tissue that met the same criteria as in vivo.
MATERIALS AND METHODS Study Population
Functionally independent elderly subjects, aged between 65 and 80, were recruited through their general practitioners. Exclusion criteria were contraindications for 7.0 T MRI (e.g., claustrophobia, metal objects such as dental implants or prostheses in or on the body), or a known psychiatric or neurologic disorder that could influence cognitive functioning, including recent nondisabling stroke (o2 years) or any disabling stroke, major depression or a history of alcohol or substance abuse. Subjects underwent a Mini-Mental State Examination 9 and had to have a score of 26 or higher for inclusion in the present study. General practitioners made a first selection against these criteria. In the period of October 2010 to 2011, 54 eligible subjects were willing to participate in the study. Twenty-two were excluded because of MR contraindications, and another eight because of other reasons. Hence, 24 individuals were included in this study. They all underwent 7.0 T MRI scanning in the University Medical Center Utrecht (UMCU, The Netherlands) with the same standardized protocol including fluid attenuated inversion recovery (FLAIR), a T 2 weighted, and a T 1 weighted sequence. The scans of two subjects could not be used because of severe motion artifacts. This resulted in a study population of 22 subjects.
The study was approved by the medical ethics committee of the UMCU and all subjects gave written informed consent according to the Declaration of Helsinki.
In Vivo Magnetic Resonance Imaging Scanning Protocol
Scans were acquired on a whole-body 7.0 T MR system (Philips Healthcare, Cleveland, OH, USA) with a volume transmit and 16-channel receive head coil (Nova Medical, Wilmington, MA, USA). Subjects included in the study later than May 2011 (nine in total) were scanned with a volume transmit and 32-channel receive head coil (Nova Medical), which, as far as we could judge, did not cause any observable differences in lesion appearance. The standardized protocol included the following sequences: 
Magnetic Resonance Imaging Rating
Histopathologically, CMIs have been described as sharply delineated microscopic ischemic lesions, often associated with gliosis and cavitation. 2, 7 Based on those features, we hypothesized that on ultra-high resolution MRI CMIs would appear as small hyperintense circumscriptwith or without a hypointense center-lesions on FLAIR, hyperintense on T 2 weighted, and hypointense or isointense on T 1 weighted images. We focused on CMIs in the cerebral cortex, because autopsy studies indicate that these lesions are particularly common in the cortex. Moreover, we expected that in the subcortical gray and white matter it would be more difficult to differentiate CMIs from other focal lesions including perivascular spaces and punctate WMHs (i.e., small focal hyperintensities on T 2 13 ). In an initial evaluation the FLAIR scans (sagittal view) of all subjects were thoroughly examined to identify possible cortical CMIs and the findings were compared with T 2 weighted and T 1 weighted scans. During this process, we did identify multiple hyperintense cortical lesions suspected to be CMIs on FLAIR, but we did not see lesions with a hypointense center. In all cases, these hyperintense FLAIR lesions were hyperintense on T 2 weighted and hypointense on the corresponding T 1 weighted scan. Based on this initial evaluation, we operationally defined possible cortical CMIs on 7.0 T MRI for further visual rating as hyperintense on FLAIR, hyperintense on T 2 weighted, and hypointense on T 1 weighted scans. Each lesion had to be detectable on all three views of the brain (sagittal, coronal, and transversal), and restricted to the cortex. Moreover, they had to be distinct from perivascular spaces. We observed that some perivascular spaces extended from the white matter into the cortex, producing changes in cortical signal intensities mimicking those of possible CMIs. Therefore, we discarded all small cortical lesions that were in direct contact with a perivascular space in the underlying white matter as possible CMIs. Based on those criteria, the MR images of all subjects were reevaluated systematically and possible cortical CMIs were scored. All identified possible cortical CMIs were inspected by a second rater, experienced in the field of neuroradiology. Both raters were blinded to clinical information such as age. In the case of disagreement, for every location consensus was reached.
When a possible cortical CMI was identified on 7.0 T, the corresponding 3.0 T FLAIR, T 2 , and T 1 weighted images were examined at the same location. This was performed by visual inspection using landmarks.
In addition, WMHs were assessed on the 3.0 T FLAIR images using the Age Related White Matter Changes scale, 13 by two independent raters. Lacunar infarctions were also identified.
Postmortem Tissue
For ex vivo MRI protocol optimization three formalin-fixed 10-mm thick coronal brain slices were used. These slices, provided by the anatomy department of the UMCU, were from subjects who had donated their brains to science; therefore, detailed subject information was unavailable. Number of definite CMIs verified on histopathologic examination. d Two cortical CMIs in the brain tissue of this subject were solely found on ultra-high resolution ex vivo T 2 (400 Â 400 Â 400 mm 3 ) in retrospect, after the CMI was identified on histopathologic examination. e One cortical CMI was found in the negative control tissue taken from the brain tissue of this subject (and could not be found again on ex vivo MRI). One additional CMI was found in close proximity to one of the CMIs that was identified on ex vivo MRI. These extra CMIs could in retrospect not be found on ex vivo MRI.
Initially, we scanned with the tissue submerged in Fomblin (Solvay Solexis, Bollate, Italy), a proton-free fluid without MR signal. Later, we scanned the tissue submerged in 4% formaldehyde solution (formalin). After careful comparison of MR image quality, it was decided to use formalin during scanning, which proved to provide better tissue-fluid contrast. After protocol optimization, 15 formalin-fixed 10-mm thick coronal brain slices from six subjects were submitted to ex vivo MRI. These subjects had undergone autopsy in our hospital, after informed consent of the family was obtained. Patients were selected from the database of the neuropathology department based on reported cerebrovascular and Alzheimer pathology on autopsy. Details of subject and brain tissue characteristics are provided in (Table 1) .
At least 2 hours in advance of scanning two coronal brain slices were placed in a plastic container, submerged in formalin. Care was taken to avoid air bubbles. Before scanning, the plastic container was sealed in a plastic bag, wrapped in a towel, and placed in the center of the MR head coil. The use of the material of these patients for this study was in accordance with local regulations and approved by the medical ethics committee of the UMCU.
Ex Vivo Magnetic Resonance Imaging Scanning Protocol
Scans were acquired overnight on the same whole-body 7.0 T MR system as the in vivo scans, with a volume transmit and 32-channel receive head coil (Nova Medical). We used two different protocols. The first ex vivo protocol included the same sequences as in vivo (FLAIR and T 2 weighted, with exception of the T 1 weighted) and is referred to as 'clinical resolution protocol.' The TI was adjusted to obtain proper nulling of the formalin, in which the postmortem tissue was submerged during scanning. Also the refocusing angle was reduced, to account for the fact that the relaxation times of formalin-fixed tissue are more reduced as compared with in vivo tissue.
The second protocol aimed to obtain an even higher resolution and is referred to as 'ultra-high resolution protocol.' In this ultra-high resolution protocol, the postmortem tissue was scanned with the following parameters: 
Sampling Procedure and Histology
The sampling procedure was established in three formalin-fixed 10-mm thick coronal brain slices, derived from subjects who had donated their brains to science (Figure 1 ). After this development stage, the following procedure was performed on the brain tissue of the patients used in this study: after the ex vivo MRI scanning session, blocks of tissue (20 Â 10 Â 0.5 mm 3 ) were cut from the sites where possible cortical CMIs were detected on the ex vivo MR images. All lesions that presented as cortical hyperintensities on both the clinical and ultra-high resolution ex vivo FLAIR as well as the T 2 weighted images were sampled. The ultra-high resolution T 2 * weighted sequence provided an extra level of detail and therefore served as a useful guide for sampling. As a negative control, two blocks of tissue in two different brain slices of two different subjects were cut from a site where no lesion was visible on any MR image. All blocks were dehydrated and preprocessed, after which they were embedded in paraffin. Further, 4-mm thick serial sections were cut using a microtome. Standard histologic staining was performed on these sections, which included a hematoxylin/eosin (for cell bodies) stain, and a Luxol fast blue & Periodic acid-Schiff (for myelin) stain. Sections were studied under a Carl Zeiss microscope, and photographs were obtained with a digital camera, mounted on top of the microscope. Sections were examined by the neuropathologist of our hospital. Cortical CMIs were determined based on the presence of a sharply delineated area of ischemia, cellular death, and tissue necrosis. Furthermore, the presence of gliosis and cavitation was noted, and lesion diameter was measured on the obtained photograph. CMIs. There were no clear differences in subject characteristics, WMH load and presence of lacunar infarctions between subjects with or without CMIs ( Table 2) . Possible cortical CMIs appeared as sharply delineated linear lesions, perpendicular to the cortical surface and extending into the lower cortical layers. All identified possible cortical CMIs were p3 mm. They were primarily identified in the parietal and frontal cortical regions (one possible cortical CMI was located in the occipital cortex). One subject had several small hyperintense cortical lesions on FLAIR and T 2 presumed to be of ischemic origin in the occipital cortex, but these were not classified as possible CMIs, because they were related to a larger area of infarction. The temporal lobes proved difficult to assess, because of a low signalto-noise ratio in these areas, which is a current known limitation of the applied 7.0 T FLAIR MR sequence. 10 Of all possible cortical CMIs, the corresponding location on 3.0 T FLAIR, T 2 , and T 1 was examined. Of the 15 possible cortical CMIs identified at 7.0 T, one was visible on both the corresponding 3.0 T T 2 and T 1 (Supplementary Figure) , another three were solely visible on the corresponding 3.0 T T 1 , but none were visible at the corresponding 3.0 T FLAIR.
RESULTS

In
Ex Vivo 7.0 T Magnetic Resonance Imaging
Characteristics and autopsy findings of the six subjects whose brain slices were used for ex vivo MRI are provided in Table 1 . In 15 slices, a total of six hyperintense cortical lesions were identified on the ultra-high as well as on the clinical resolution FLAIR and T 2 ex vivo MR images. Appearance of the lesions was similar to the possible CMIs on in vivo MRI. The six lesions were sampled and further processed. At histopathologic examination, all but one of these lesions could be identified on the corresponding section. On microscopy all five lesions that were identified appeared as focal lesions of pallor with cellular death, attributed to ischemia, and moderate gliosis in the surrounding tissue (Figure 4 ). Based on these distinctive characteristics, these ischemic lesions were classified by the neuropathologist as definite CMIs. Their sizes varied from B1,200 to 2,500 mm as measured on the obtained microscopic photographs.
Microscopic examination identified three additional small cortical CMIs that were not identified on the initial visual inspection of the ex vivo MRI. Two of these CMIs could be identified after reinspection of the ex vivo MR images, on the corresponding ultra-high resolution T 2 weighted MR image (one is depicted in Figure 5 ). These CMIs measured 470 and 1,300 mm, respectively. The third CMI (780 mm) was located close to a sulcus which limited its detection, on ex vivo MRI, possibly because of partial volume effects. In the two blocks of tissue that were sampled from regions where no lesion was visible on the MR images (negative controls), one small cavitated cortical CMI (670 mm) was found on histopathologic examination. This cortical CMI could not be found on ex vivo MRI, after reinspection of the corresponding images, possible also because of a partial volume effect.
DISCUSSION
This study shows that CMIs can be detected noninvasively during life. We observed small cortical lesions on 7.0 T MR images of nondemented elderly subjects that were compatible with our predefined features of cortical CMIs. Histopathologic validation of lesions with similar characteristics on ex vivo MRI showed that these lesions were indeed CMIs.
In the ex vivo part of this study, CMIs that appeared as focal lesions of pallor with neuronal loss, attributed to ischemia, on histology, gave a hyperintense signal on FLAIR and T 2 weighted ex vivo MR images. 2, 7 In the neuropathologic literature, there is no consensus on the definition of the size of a CMI. Some studies report an upper limit for CMI size as 'microscopic' or 'not visible to the naked eye,' but several studies also classify lesions up to a few mm in size as CMIs. 5, 6 Our findings suggest that with ultra-high resolution ex vivo 7.0 T MRI CMIs larger than 0.5 mm can be detected. With clinical resolution 7.0 T MRI (both ex vivo and in vivo) only the larger CMIs (Z1 mm) can be detected. Compared with neuropathology, in vivo MRI has the obvious advantage that it allows (repeated) assessment of living subjects, thus allowing longitudinal studies of CMIs in relation to other clinical parameters. Another advantage is that MRI provides coverage of almost the complete brain, while histologic studies typically have to rely on sampling of only a small proportion of the brain in different areas. At the 50 mm to 0.5 mm range, however, our current MRI protocol will miss CMIs. In that perspective, the lesions that were identified with in vivo MRI in the current study are more likely to be the 'top of the iceberg' of total CMI load. It is yet unclear if the etiology of these smallest CMIs is identical to that of the somewhat larger lesions. Nonetheless, the prevalence of cortical CMIs in 6 of 22 (27.3%) elderly subjects in the in vivo part of the current study is in the same range (i.e., 24%), as the neuropathologic findings reported in nondemented elderly subjects. 6 Ex vivo MRI proves to be a valuable tool in determining MR markers in brain diseases with multiple small focal abnormalities such as vascular lesions and demyelination, providing whole-brain coverage and targeted sampling for histopathologic examination. [14] [15] [16] A recent study suggested that prolonged storage (46 years) of formalin-fixed tissue results in subtle histology artifacts, which sometimes on ex vivo MRI is indistinguishable from genuine brain pathology. 17 In our case, we have solely used postmortem brain tissue that has been stored for no longer than 15 months, therefore we assume our samples are not susceptible for mentioned alterations in the tissue and on the corresponding MR images.
Previously, CMIs have been identified on ex vivo (7.0 T) MRI in brain tissue of a single patient with CADASIL (cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy). 18 The brain tissue of this patient presented with several CMIs on high-resolution T 2 * weighted scans, which were histopathologically validated. 18 Possible CMIs have recently been described in an in vivo MRI study at 3.0 T. 19 That study, which did not verify the nature of the observed lesions histologically, included 70 subjects with AD or cerebrovascular disease and observed small intracortical high signal lesions suspected to be CMIs on both advanced double inversion recovery and 3D FLAIR images with high in-plane resolutions in only nine subjects. 19 The lesions depicted in that paper are of similar appearance as the lesions depicted in our study, albeit of larger size. Apparently, it is also possible to detect CMIs at field strengths lower than 7.0 T, as our findings at 3.0 T also show. Probably, lesion detection at lower field strengths can be improved by further protocol optimization. We recommend that such protocols include at least heavily T 2 weighted FLAIR, T 2 , and T 1 weighted sequences. A separate study would be needed to investigate to what extent our 7.0 T results can be translated to 3.0 T MRI, and how a 3.0 T protocol should be optimized for this purpose. However, we expect that 7.0 T definitely is more sensitive for CMI detection compared with 3.0 T, either by an increased signal-to-noise ratio, improved contrast, a higher resolution, or by a combination of these factors. 20 Cerebral microinfarcts have been studied extensively in neuropathologic studies. A systematic review of 32 of these studies, involving neuropathologic data of over 10,000 subjects, emphasized the potential clinical relevance of CMIs. 6 Cerebral microinfarcts are an important correlate of aging-related cognitive impairment and dementia and vascular disease. 7, [21] [22] [23] [24] Although they are small, autopsy data suggest that CMIs might be the most widespread form of brain infarction and are thus conceivable to cause substantial clinical symptoms. 5, 25, 26 In a clinicopathologic study examining the brains of 285 autopsied decedents as part of the HAAS (Honolulu-Asia Aging Study), it was found that neither large infarcts, lacunar infarctions, nor hemorrhages added significantly to the variance in the final antemortem cognitive test score as established by the CASI (Cognitive Abilities Screening Instrument). Only CMIs were independently associated with poor CASI test scores. 7 While the role of CMIs in aging and dementia is increasingly recognized, the underlying pathophysiology of CMIs is not completely understood. A recent neuropathologic study suggests that CMIs are an end stage of microvascular pathology in SVD. 27 Now CMIs prove to be detectable noninvasively during life, as shown in the present study, the clinical significance, etiology, and prognostic value of CMIs can be further established. Our study was designed to assess the possibility to detect CMIs in vivo, and cannot yet address these issues. Our findings thus set the stage for further studies on CMIs in larger samples of patients with different clinical diagnoses and on the relation between CMIs and cognitive functioning and other SVD correlates, such as lacunar infarctions, WMHs, and microbleeds. The strength of this work is the use of advanced imaging technique in a combined in vivo-ex vivo correlation study. Our study does also have several limitations. First of all, the histopathologic verification of the possible CMIs detected in vivo relied on autopsy material of other subjects. Moreover, while the in vivo study concerned nondemented healthy elderly subjects, postmortem tissue of patients with Alzheimer and vascular pathology was used for the ex vivo validation study. We specifically decided to focus on patients with advanced pathology in the ex vivo study because we wanted to enrich our sample for microvascular pathology, thus increasing the chances of finding lesions in a limited number of brain slices. Nevertheless, based on the current literature there is no evidence that the key histologic features of CMIs differ between people with or without dementia. Furthermore, the operational definition of CMIs is derived from the set of subjects in this study and applied to the same set. This definition might have to be adjusted in the future, or extended for other subtypes of CMIs, based on emerging insights from further studies on in vivo and ex vivo MRI. Another limitation was that the ex vivo scanning protocol did not include a T 1 weighted sequence. As T 1 relaxation in formalin-fixed tissue is severely reduced compared with in vivo it proved difficult to develop such a sequence resembling the in vivo state. 28 Finally, there are still strict safety regulations for 7.0 T MRI that may have led to selection bias in the in vivo study.
Conclusion
By combining high-resolution in vivo MRI and ex vivo MRI with histologic verification, this study provides strong evidence that cortical CMIs can be detected in vivo. Cortical CMIs are thus a novel in vivo marker of SVD that can be of great value in further studies into the role of vascular disease in aging-related cognitive decline and dementia. 
